Takeda's dengue vaccine candidate shows promise
Japanese pharma firm Takeda has said that its dengue vaccine candidate, TAK-003, prevented 84 per cent of hospitalised dengue cases and 61 per cent of symptomatic cases. The 4.5-year-long phase-3 clinical trial, which included over 20,000 children and teenagers, identified no "important safety risks". The data was presented at the 8th Northern European Conference on Travel Medicine.
PGIMER Gets WHO award for tobacco control
Recognising its efforts in advancing tobacco control, the WHO has awarded the Resource Centre for Tobacco Control (e-RCTC) of the Department of Community Medicine and School of Public Health at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh with the Regional Director Special Recognition Award.
Health ministry notifies rules for ART clinics and banks
The health ministry has notified the rules including the registration process, staff requirement, minimum equipment required and the license granting format for Assisted Reproductive Technology (ART) in the country.
NEI researchers discover new genetic eye disease
Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula, a small part of the light-sensing retina needed for sharp, central vision.
